A federal judge ruled July 8 in favor of a cohort of pharmaceutical companies, including Thousand Oaks-based Amgen, blocking a proposed rule that would have forced them to disclose the list prices of their drugs in television advertisements. The rule was announced in October, and would have gone into effect July 9. Amgen, along with…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
